Firestormm
Senior Member
- Messages
- 5,055
- Location
- Cornwall England
I'm actually not certain the drugs are currently being used by ME/CFS patients. I don't recall that from any of the communications around the study.
In terms of footing the bill, the Association funded the study that identified these targets. I don't know who is footing the bill for the first trial - maybe Biovista and Association combined?
Morning Jenny, there's an article on the way about Suzanne's talk though I must confess that at this time of the morning, I am confused by my recollection of it - I thought these drugs might have come about through the clinicians' survey i.e. they are known and used by some patients and prescribed by some physicians; but this 'drug repurposing' as Nielk correctly highlights: well, it's thrown my thinking off target So I don't know what they could possibly be investigating. However, even a 'trawl of the literature' would be CFS literature so I guess the drugs will be recognised by the community. Bums. We'll all have to wait, though for how long I couldn't say...